Cerevel Therapeutics Inc... (CERE)
NASDAQ: CERE
· Real-Time Price · USD
44.96
0.33 (0.74%)
At close: Jul 31, 2024, 10:00 PM
Cerevel Therapeutics Revenue
Cerevel Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2024, Cerevel Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
355
Market Cap
8.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | -100.00% |
| Aug 31, 2015 | 2.72M | +13.14% |
| Aug 31, 2014 | 2.4M | -54.15% |
| Aug 31, 2013 | 5.24M | -2.38% |
| Aug 31, 2012 | 5.37M | n/a |